Javascript must be enabled to continue!
Going Hollywood: Nordic Directors in American Cinema
View through CrossRef
Starting with a historical overview of the presence of Nordic directors in Hollywood, this chapter aims to explore the critical mass of Nordic directorial talents in contemporary American cinema. It interrogates their importance for the transnational dynamism of Nordic cinema outside its normative national borders and reveals how vitally Nordic directors have contributed to an increasingly globalised Hollywood. By configuring Nordic directors within different temporal and categorical groupings, this study charts differences and similarities of ‘Nordic’ stylistic and thematic traits when migrating into Hollywood cinema.
Title: Going Hollywood: Nordic Directors in American Cinema
Description:
Starting with a historical overview of the presence of Nordic directors in Hollywood, this chapter aims to explore the critical mass of Nordic directorial talents in contemporary American cinema.
It interrogates their importance for the transnational dynamism of Nordic cinema outside its normative national borders and reveals how vitally Nordic directors have contributed to an increasingly globalised Hollywood.
By configuring Nordic directors within different temporal and categorical groupings, this study charts differences and similarities of ‘Nordic’ stylistic and thematic traits when migrating into Hollywood cinema.
Related Results
Alternative Entrances: Phillip Noyce and Sydney’s Counterculture
Alternative Entrances: Phillip Noyce and Sydney’s Counterculture
Phillip Noyce is one of Australia’s most prominent film makers—a successful feature film director with both iconic Australian narratives and many a Hollywood blockbuster under his ...
Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)
Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)
Abstract
Introduction
The short half-life of standard factor VIII (FVIII) products means that frequent injections (3 to 4 times/week) are needed for e...
A Phase 1b, Dose-Finding Study Of Ruxolitinib Plus Panobinostat In Patients With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF): Identification Of The Recommended Phase 2 Dose
A Phase 1b, Dose-Finding Study Of Ruxolitinib Plus Panobinostat In Patients With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF): Identification Of The Recommended Phase 2 Dose
Abstract
Background
Myelofibrosis (MF) is a myeloproliferative neoplasm associated with progressive, debilitating symptoms that ...
Poetry of Image: Key Issues of the History and Aesthetics of Iranian Auteur Cinema
Poetry of Image: Key Issues of the History and Aesthetics of Iranian Auteur Cinema
Iranian cinema, with its 100-year history, is an integral part of the world’s spiritual and cultural heritage and cinematographic art.
Iranian cinema has a rich and diverse history...
Italian Cinema
Italian Cinema
Italian national cinema developed quickly between the last decade of the 19th century and the outbreak of World War I (particularly in Turin and also in Rome), and it won a sizeabl...
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Abstract
Background: Imetelstat, a first in class specific telomerase inhibitor, induced hematologic responses in all patients (pts) with essential thrombocythemia (...
Effects of Hollywood Cinema on Pakistan’s Youth Lifestyle and Behaviour Patterns
Effects of Hollywood Cinema on Pakistan’s Youth Lifestyle and Behaviour Patterns
This study highlights the efforts of providing a concise overview on the impact of Hollywood cinema on behavior patterns and the lifestyle of Pakistani youth and having reputed eff...
Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Hemophilia a or B with Inhibitors: Results from explorer4, a Phase 2, Randomized, Open-Label, Controlled Trial
Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Hemophilia a or B with Inhibitors: Results from explorer4, a Phase 2, Randomized, Open-Label, Controlled Trial
Introduction Concizumab is an anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody in clinical development for the subcutaneous prophylactic treatment of hemophilia pati...

